Literature DB >> 7476914

Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells.

T Priestley1, P Laughton, J Myers, B Le Bourdellés, J Kerby, P J Whiting.   

Abstract

The pharmacological properties of two recombinant human N-methyl-D-aspartate (NMDA) receptor subtypes, comprising either NR1a/NR2A or NR1a/NR2B subunits permanently transfected into mouse L(tk-) cells, have been compared using whole-cell voltage-clamp electrophysiology. Glutamate was a full agonist at both receptors, having a modestly but statistically significant (p < 0.002) higher affinity for the NR2B- than the NR2A-containing receptor (microscopic Kd [mKd] = 0.76 and 0.43 microM, respectively). In comparison to glutamate, NMDA, quinolinic acid, and cis-2,3-piperidinedicarboxylic acid were partial agonists at both receptor subtypes. Maximal amplitude currents resulted when glutamate-site agonists were combined with either glycine or D-serine; both of these amino acids were, therefore, defined as full agonists at the glycine site. Glycine had an approximately 10-fold higher affinity (p < 0.0001) for NR2B- than for NR2A-containing receptors (mKd = 0.057 and 0.53 microM, respectively). D-Cycloserine, (+)-(3R)-3-amino-1-hydroxypyrrolidin-2-one, (+)-cis-(4R)-methyl-(3R)-amino-1-hydroxypyrrolidin-2-one, and 1-aminocyclobutanecarboxylic acid also had higher affinities for the NR2B-containing receptor but were partial agonists, at both receptor subtypes, unlike glycine. Agonist-evoked whole-cell currents were antagonized by D-(-)-2-amino-5-phosphonopentanoic acid, cis-4-(phosphonomethyl)piperidine-2-carboxylic acid, and 3-((R)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid, all of which had slightly, but statistically significant, higher affinities (2.2-, 2.8-, and 5.5-fold, respectively) for the NR2A-containing receptor. Responses were also antagonized by the glycine-site antagonists 7-chlorokynurenic acid, 7-chloro-4-hydroxy-3-(3-phenoxy)phenylquinolin-2-(1H)-one, and (+/=)-4-(trans)-2-carboxy-5,7-dichloro-4-phenylaminocarbonylamino- 1,2,3,4- tetrahydroquinoline. The atypical NMDA antagonist ifenprodil showed the largest separation in functional affinity (IC50 values, 0.6 and 175 microM at NR2B- and NR2A-containing receptors, respectively). These experiments demonstrate the usefulness of permanently transfected L(tk-) cells for electrophysiological studies of recombinant NMDA receptor function and provide the first detailed functional pharmacological analysis of human NMDA receptor subtypes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7476914

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  73 in total

1.  Developmental profile of the changing properties of NMDA receptors at cerebellar mossy fiber-granule cell synapses.

Authors:  L Cathala; C Misra; S Cull-Candy
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

Review 2.  Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators.

Authors:  Daniel T Monaghan; Mark W Irvine; Blaise Mathias Costa; Guangyu Fang; David E Jane
Journal:  Neurochem Int       Date:  2012-01-17       Impact factor: 3.921

Review 3.  Glutamate receptor ion channels: structure, regulation, and function.

Authors:  Stephen F Traynelis; Lonnie P Wollmuth; Chris J McBain; Frank S Menniti; Katie M Vance; Kevin K Ogden; Kasper B Hansen; Hongjie Yuan; Scott J Myers; Ray Dingledine
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

4.  Stoichiometry of N-methyl-D-aspartate receptors within the suprachiasmatic nucleus.

Authors:  J P Clark; P Kofuji
Journal:  J Neurophysiol       Date:  2010-04-21       Impact factor: 2.714

5.  Relating NMDA receptor function to receptor subunit composition: limitations of the pharmacological approach.

Authors:  Jacques Neyton; Pierre Paoletti
Journal:  J Neurosci       Date:  2006-02-01       Impact factor: 6.167

6.  Obligatory role of NR2A for metaplasticity in visual cortex.

Authors:  Benjamin D Philpot; Kathleen K A Cho; Mark F Bear
Journal:  Neuron       Date:  2007-02-15       Impact factor: 17.173

7.  Synapse-specific expression of functional presynaptic NMDA receptors in rat somatosensory cortex.

Authors:  Daniel J Brasier; Daniel E Feldman
Journal:  J Neurosci       Date:  2008-02-27       Impact factor: 6.167

8.  Amygdala infusions of an NR2B-selective or an NR2A-preferring NMDA receptor antagonist differentially influence fear conditioning and expression in the fear-potentiated startle test.

Authors:  David L Walker; Michael Davis
Journal:  Learn Mem       Date:  2008-01-28       Impact factor: 2.460

9.  The immediate early gene early growth response gene 3 mediates adaptation to stress and novelty.

Authors:  A Gallitano-Mendel; Y Izumi; K Tokuda; C F Zorumski; M P Howell; L J Muglia; D F Wozniak; J Milbrandt
Journal:  Neuroscience       Date:  2007-08-09       Impact factor: 3.590

10.  Spontaneous and evoked glutamate release activates two populations of NMDA receptors with limited overlap.

Authors:  Deniz Atasoy; Mert Ertunc; Krista L Moulder; Justin Blackwell; ChiHye Chung; Jianzhong Su; Ege T Kavalali
Journal:  J Neurosci       Date:  2008-10-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.